Cross talk between COX-2 inhibitor and hyaluronic acid in osteoarthritic chondrocytes.

International journal of molecular medicine

Volumn 14, Issue 2, 2004, Pages 139-144

  Takahashi, Toshiaki ^a   Uemura, Yoshiki ^a   Taguchi, Hirokuni ^a   Ogawa, Yasuhiro ^a   Yoshida, Shoji ^a   Toda, Michio ^a   Kobayashi, Toshihiro ^a   Seguchi, Harumichi ^a   Tani, Toshikazu ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLYCOSAMINOGLYCAN; HYALURONIC ACID; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL MEMBRANE POTENTIAL; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; HUMAN; INFLAMMATION; METABOLISM; MITOCHONDRION; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; BLOTTING, WESTERN; CARTILAGE; CHONDROCYTES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG SYNERGISM; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; NITRIC OXIDE; OSTEOARTHRITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIME FACTORS;

MLCS; MLOWN;

EID: 16644379542     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.14.2.139     Document Type: Article

References (0)